If you’re considering autism treatment at a stem cell therapy clinic, you may be overwhelmed reading about all the different types of stem cells used in stem cell therapy.
In this article, we’ll help you better understand one type of stem cell - neural stem cells. We’ll explain what neural stem cells are, their potential for treating autism and the future of neural stem cells in autism treatment.
A neural stem cell (NSC) is a stem cell that can differentiate into cells of the central nervous system, including:
While there are many factors of autism, autism is in part a neurological disorder. Children with autism often show signs of impaired brain development and unusual patterns of neural connectivity. According to research children with autism also suffer from impaired blood flow in the brain.
In stem cell treatment for autism, stems can replace damaged neurons by migrating to the site of damaged neurons, differentiating into neural cells, promoting the growth of new healthy neurons and exerting neuroprotective effects.
Photo by Robina Weermeijer on Unsplash
Other ways neural stem cells may be able to improve neurological conditions like autism include:
Through all of these effects, neural stem cells have the potential to restore proper brain function and brain development in children with autism, thereby reducing autism symptoms.
According to research, neural stem cells can restore nerve tissue by replacing damaged cells and secreting neurotrophic growth factors that promote neurogenesis. This is particularly effective in treating neurological conditions like autism. NSCs also play a crucial role in regenerating damaged neuronal circuits.
Photo by Louis Reed on Unsplash
One challenge of using NSCs in treating autism is finding an available and ethical source of NSCs. Research has not yet been able to define the optimal source for neural stem cells. Since it’s not feasible to extract NSCs from the brain, research is focused on finding viable sources for NSCs.
According to research, one safe, effective and available source of NSCs is umbilical cord blood. Sourcing NSCs from an umbilical cord is also ethical, since it is typically discarded after birth.
In addition to challenges with sourcing NSCs, it might also be difficult to translate the successful treatment outcomes in animal studies to treatment in a stem cell therapy clinic.
At the moment, NSC therapy is still in its early stages of development. Therefore, the future of NSC treatment for autism will focus on finding the best delivery methods for NSCs, developing standardized treatment protocols and identifying the most effective sources for obtaining NSCs.
According to research, it’s also essential to develop protocols that can direct the differentiation of NSCs, in order for them to be effective in treating disease.
Because NSCs can regenerate damaged neurons, they hold great potential in treating neurological conditions like autism.
The development of NSCs in treating autism requires collaboration across various institutions, including academic institutions, stem cell treatment clinics and regulatory agencies.
Academic institutions can share findings and data with each other to identify optimal treatment protocols and NSC sources. By sharing data and collaborating, they can accelerate the discovery process and make NSCs suitable for clinical application sooner.
Collaboration between academic institutions and stem cell treatment clinics like Swiss Medica can help make NSC treatment a viable option for treating autism. Stem cell treatment centers can provide valuable insights into treatment protocols, administration methods and stem cell sources.
Finally, working together with regulatory bodies can ensure the safe administration of NSCs in treating autism. Policymakers can also allocate funds to NSC treatment research.
There are many factors of autism, but neurological issues remain one of the most important. Fortunately, neural stem cells (NSCs) have the potential to treat these neurological issues by differentiating into neurons, stimulating the growth of blood vessels and reducing neuroinflammation.
However, NSCs still face some challenges. Researchers must find a suitable source for NSCs, and develop standardized treatment protocols and optimal delivery methods. With collaboration between academic institutions, stem cell clinics and regulatory bodies, NSC treatment may soon be suitable for clinical applications.
